Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Aclaris Therapeutics (ACRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
16 analysts
Options Flow (P/C)
—
Avg Consensus PT
$10
+157.5%
Highest Price Target
$16
+318.3%
Lowest Price Target
$1
-73.9%
Short Interest
11.6%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Canaccord Genuity | Edward Nash— | +239.9% | $10 → $13 | Maintained | Buy |
| Oct 28, 2026 | Wedbush | Martin Fan — | +109.2% | $10 → $8 | Maintained | Outperform |